secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001104659-25-062559
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics sets 2025 annual meeting for August 29; proxy deadlines revised
--------------------------------------------------------------------------------

- Annual meeting scheduled for August 29, 2025; record date for voting is July 8, 2025.
- Stockholder proposals under Rule 14a-8 must be received by July 5, 2025 for inclusion in proxy materials.
- Director nominations or other proposals not seeking inclusion must be delivered by July 5, 2025.
- Universal proxy rule compliance notice for director nominees also due by July 5, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465925062559/0001104659-25-062559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465925062559/tm2518991d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-062559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer